13 results on '"Romagnoli, V."'
Search Results
2. Low viremic HBeAg negative HBsAg carriers: clinical outcome and non invasive diagnostic accuracy for chronic hepatitis B or inactive infection by combinations of HBV markers
3. Mir-B-Index: A Candidate Bio-Marker to Identify the Immune Control of HBV Infection in Chronic Hepatitis B Patients Treated with Nucleos(t)ide-Analogues
4. P0635 : Chronic hepatitis B treatment individualization by means of serum HBsAg and Mir-B-Index kinetics
5. P1202 EARLY PREDICTION OF SUSTAINED VIROLOGIC RESPONSE BY HCV CORE ANTIGEN KINETICS IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON PLUS RIBAVIRIN
6. P688 LONG-TERM OUTCOME OF INACTIVE AND LOW VIREMIC HBeAg NEGATIVE ACTIVE CARRIERS: BENIGN ONE DIRECTION TRANSITION TOWARDS SPONTANEOUS HBsAg CLEARANCE
7. FRI-112 - Mir-B-Index: A Candidate Bio-Marker to Identify the Immune Control of HBV Infection in Chronic Hepatitis B Patients Treated with Nucleos(t)ide-Analogues
8. 632 AETIOLOGY OF CHRONIC LIVER DISEASE INFLUENCES CLINICAL PRESENTATION AND OUTCOME OF HEPATOCELLULAR CARCINOMA: A SINGLE CENTER COHORT STUDY
9. 357 PRE-S HBV MUTANTS DO NOT AFFECT HBSAG SERUM LEVELS IN HBEAG NEGATIVE GENOTYPE D CARRIERS, BUT ARE ASSOCIATED WITH LIVER DISEASE STAGE AND OLDER AGE
10. 249 ACCURATE PERSONALIZATION OF PEG-IFN+RBV TREATMENT DURATION BASED ON THE DECLINE OF HCV INFECTED CELLS COMPUTED DURING THE 1ST MONTH OF THERAPY
11. 639 MODELLING INFECTED CELL DYNAMICS BY WEEK 4 HCV RNA AND ALT KINETICS ALLOWS FOR INDIVIDUAL TAILORING OF TREATMENT DURATION IN CHRONIC HEPATITIS C PATIENTS
12. 602 THE CANDIDATE HCV E1E2MF59 VACCINE IS SAFE IN CHRONIC HEPATITIS C PATIENTS AND ACCELLERATES THE SECOND PHASE VIRAL DECLINE UPON PRIMARY RESPONSE TO PEG-INTERFERON-2A/RIBAVIRIN THERAPY
13. 249 ACCURATE PERSONALIZATION OF PEG-IFN+RBV TREATMENT DURATION BASED ON THE DECLINE OF HCV INFECTED CELLS COMPUTED DURING THE 1ST MONTH OF THERAPY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.